09.07.2015 Views

guidelines on variations to a registered pharmaceutical product

guidelines on variations to a registered pharmaceutical product

guidelines on variations to a registered pharmaceutical product

SHOW MORE
SHOW LESS
  • No tags were found...

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Guidelines <strong>on</strong> Variati<strong>on</strong>s <strong>to</strong> a Registered Pharmaceutical ProductDescripti<strong>on</strong> of changeC<strong>on</strong>diti<strong>on</strong>s <strong>to</strong>be fulfilledDocumentati<strong>on</strong>requiredReportingtype44 Change in the package size involving:44a44bchange in the number of units (e.g. tablets,ampoules etc.) in a packagechange in the fill weight/fill volume of n<strong>on</strong>parenteralmultidose <strong>product</strong>sC<strong>on</strong>diti<strong>on</strong>s <strong>to</strong> be fulfilled1-2 1-3 IN1-2 1-3 Vmin1. The change is c<strong>on</strong>sistent with the posology and treatment durati<strong>on</strong> accepted in the SmPC.2. No change in the primary packaging material.Documentati<strong>on</strong> required1. Justificati<strong>on</strong> for the new pack-size, indicating that the new size is c<strong>on</strong>sistent with the dosage regimenand durati<strong>on</strong> of use as accepted in the SmPC.2. A written commitment that stability studies will be c<strong>on</strong>ducted in accordance with NDA <str<strong>on</strong>g>guidelines</str<strong>on</strong>g> for<strong>product</strong>s where stability parameters could be affected.3. Samples of the <strong>product</strong>Descripti<strong>on</strong> of changeC<strong>on</strong>diti<strong>on</strong>s <strong>to</strong>be fulfilledDocumentati<strong>on</strong>requiredReportingtype45 Change in the shape or dimensi<strong>on</strong>s of the c<strong>on</strong>tainer or closure for:45 a n<strong>on</strong>-sterile FPPs 1-2 1-3 IN45 b sterile FPPs 1-2 1-4 VminC<strong>on</strong>diti<strong>on</strong>s <strong>to</strong> be fulfilled1. No change in the qualitative or quantitative compositi<strong>on</strong> of the c<strong>on</strong>tainer and/or closure.2. The change does not c<strong>on</strong>cern a fundamental part of the packaging material, which could affect thedelivery, use, safety or stability of the FPP.Documentati<strong>on</strong> required1. Samples of the <strong>product</strong>.2. Informati<strong>on</strong> <strong>on</strong> the proposed c<strong>on</strong>tainer-closure system (e.g. descripti<strong>on</strong>, materials of c<strong>on</strong>structi<strong>on</strong>,specificati<strong>on</strong>s etc.).3. In the case of a change in the headspace, a change in the surface/volume ratio or a change in thethickness of a packaging comp<strong>on</strong>ent: stability summary and c<strong>on</strong>clusi<strong>on</strong>s, results for a minimum oftwo batches of pilot or <strong>product</strong>i<strong>on</strong> scale, of three (3) m<strong>on</strong>ths of accelerated (and intermediate, asappropriate) and three (3) m<strong>on</strong>ths of l<strong>on</strong>g-term testing and where applicable, results of pho<strong>to</strong> stabilitystudies.Doc. No.: DAR/GDL/005 Revisi<strong>on</strong> Date: 8 th July 2013 Review Due Date: 16 th July 2016Revisi<strong>on</strong> No.: 1 Effective Date : 16 th July 2013 Page 52 of 70

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!